Filing Details

Accession Number:
0001104659-24-003330
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-01-11 16:37:53
Reporting Period:
2024-01-10
Accepted Time:
2024-01-11 16:37:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1297184 Amphastar Pharmaceuticals Inc. AMPH Pharmaceutical Preparations (2834) 330702205
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1611156 Z. Mary Luo C/O Amphastar Pharmaceuticals, Inc.
11570 6Th Street
Rancho Cucamonga CA 91730
Coo,Chief Scientist & Chairman Yes Yes Yes No
1611157 Y. Jack Zhang C/O Amphastar Pharmaceuticals, Inc.
11570 6Th Street
Rancho Cucamonga CA 91730
Ceo & Chief Scientific Officer Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-01-10 78,236 $54.32 1,157,566 No 4 S Direct
Common Stock Disposition 2024-01-10 50,514 $54.89 1,107,052 No 4 S Direct
Common Stock Disposition 2024-01-10 920 $55.95 1,106,132 No 4 S Direct
Common Stock Disposition 2024-01-10 1,716 $57.00 1,104,416 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,078,718 Indirect See footnote
Common Stock 6,827,679 Indirect See footnote
Common Stock 5,000 Indirect See footnote
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2023.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.67 to $54.665, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (5) to this Form 4.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.67 to $55.66, inclusive.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.675 to $56.52, inclusive.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.97 to $57.26, inclusive.
  6. The securities are held of record by Jack Y. Zhang. The reporting persons are husband and wife.
  7. The shares are held of record by Applied Physics & Chemistry Laboratories, Inc., of which the reporting persons and The Bill Luobei Zhang 2004 Irrevocable Trust are the sole owners.
  8. The shares are held of record by the reporting persons' son. The reporting persons disclaim beneficial ownership of these shares, and the inclusion of these shares in this report should not be deemed an admission of beneficial ownership of any such shares for purposes of Section 16, or for any other purpose.